Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer

Journal of Cancer Research and Clinical Oncology
Si-Si ChenXin Sun

Abstract

This study was designed to detect patients with early NSCLC with tentatively using the stem signatures associated autoantibodies (AAbs), and to evaluate its latent values in the early diagnosis and precise prognosis prediction. The serum concentrations of selective antibodies were quantitated by enzyme-linked immunosorbent assay (ELISA), and a total of 458 cases were enrolled (training set = 401; validation set = 57). TCGA databases were used to analyze the distinct expressions and prognostic values of related genes. The optimal cut-off values were 11.60 U/ml for P53, 4.90 U/ml for MAGEA1, 3.85 U/ml for SOX2, and 7.05U/ml for PGP9.5. We found that the stem signatures associated antibodies of MAGEA1, PGP9.5, SOX2, and TP53 exhibited high expressions in NSCLC, negatively correlating with the overall survival (OS) (P < 0.05). In the test groups, the diagnosis sensitivity of P53, PGP9.5, SOX2, and MAGEA1 reached to 21.5%, 39.0%, 50.3%, and 35.0%, respectively, and the specificity reached to 98.7%, 99.4%, 92.2%, and 97.4%. The four candidates' panel gave a sensitivity of 71.8% with a specificity of 89%. In the validation group, the detection of the four antibodies in early diagnosis of NSCLC also exhibited high specificity and sensi...Continue Reading

References

Apr 8, 2004·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
Mar 8, 2007·JAMA : the Journal of the American Medical Association·Peter B BachColin B Begg
Mar 16, 2007·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
Feb 4, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A MurrayJ F R Robertson
Apr 21, 2010·Annals of Internal Medicine·Jennifer M CroswellBarnett S Kramer
Aug 3, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P BoyleJ F R Robertson
Jul 1, 2011·The New England Journal of Medicine·UNKNOWN National Lung Screening Trial Research TeamJoRean D Sicks
Jul 8, 2011·Cancer Prevention Research·Stephen LamJohn F R Robertson
Apr 12, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Caroline J ChapmanJohn F R Robertson
May 23, 2012·JAMA : the Journal of the American Medical Association·Peter B BachFrank C Detterbeck
Jun 21, 2012·Biochemical and Biophysical Research Communications·Yibing YaoQinghua Zhou
Jan 25, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Heidi RobertsUNKNOWN Lung Cancer Screening Guideline Development Group
Jul 9, 2016·Nature Reviews. Cancer·Ashley J Vargas, Curtis C Harris
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 24, 2017·Surgery Today·Haruhiko Nakamura, Toshihide Nishimura
Sep 8, 2017·Open Biology·Sean Blandin KnightCaroline Dive
Oct 13, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Pei LiJian-Ying Zhang
Dec 7, 2017·The Lancet Oncology·Matthijs OudkerkJohn K Field
Jan 27, 2018·Biomarker Insights·Peter J MazzoneVictoria Doseeva
Dec 12, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Luis M SeijoLuis M Montuenga

❮ Previous
Next ❯

Citations

Nov 23, 2020·Journal of Cancer Research and Clinical Oncology·Siyuan HaoJia Ma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.